Results 31 to 40 of about 3,110,681 (290)

Efficacy of chemotherapy after hormone therapy for hormone receptor–positive metastatic breast cancer

open access: yesSAGE Open Medicine, 2014
Objective: According to the guidelines for metastatic breast cancer, hormone therapy for hormone receptor–positive metastatic breast cancer without life-threatening metastasis should be received prior to chemotherapy.
Ryutaro Mori, Yasuko Nagao
doaj   +1 more source

Menopausal hormone therapy and venous thromboembolism

open access: yesMenopause Review, 2014
Menopausal hormone therapy (MHT) is the most effective method of treating vasomotor symptoms and other climacteric symptoms related to estrogen deficiency in peri- and postmenopausal period.
Małgorzata Bińkowska
doaj   +1 more source

Breast Cancer Series: Hormone Therapy

open access: yesEDIS, 2011
Women who are at high risk of getting breast cancer and women who have had breast cancer may be prescribed daily oral medications to block the estrogen receptor site or decrease the production of estrogen. This 2-page fact sheet describes various hormone
Karen C. Daily, Martha C. Monroe
doaj   +5 more sources

Keratoconus progression associated with hormone replacement therapy

open access: yesAmerican Journal of Ophthalmology Case Reports, 2019
Purpose: To report a postmenopausal patient with keratoconus who experienced significant progression after using hormone replacement therapy. Observations: A 51-year-old woman with previously stable keratoconus presented with acute disease progression ...
Giulia Coco   +4 more
doaj   +1 more source

Growth hormone therapy in HHRH

open access: yesBone Reports, 2022
Background: Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) (SLC34A3 gene, OMIM 241530) is an autosomal recessive disorder that results in a loss of function of the sodium-phosphate NPT2c channel at the proximal tubule.
Guido Filler, MD, PhD   +6 more
doaj   +1 more source

Hormonal Therapies and Osteoporosis [PDF]

open access: yesILAR Journal, 2004
Osteoporosis, now defined as a disease characterized by low bone mass and a microarchitectural deterioration of bone tissue leading to enhanced bone fragility and fracture risk, is a major public health problem. Classic hormonal therapies to prevent and treat osteoporosis associated with menopause have recently been questioned due to the risk/benefit ...
openaire   +2 more sources

Which patients with prostate cancer are actually candidates for hormone therapy?

open access: yesInternational Brazilian Journal of Urology, 2004
In this article, we will try to address the following aspects: which factors are responsible of the introduction of new candidates for hormone therapy in prostate cancer, who are actually candidates for hormone therapy, classifying them on the basis of ...
Alessandro Sciarra   +5 more
doaj   +1 more source

Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.

open access: yesPLoS Medicine, 2011
BackgroundEven after the Women's Health Initiative (WHI) found that the risks of menopausal hormone therapy (hormone therapy) outweighed benefit for asymptomatic women, about half of gynecologists in the United States continued to believe that hormones ...
Adriane Fugh-Berman   +4 more
doaj   +1 more source

Growth Hormone Deficiency in the Transition Period

open access: yesEndocrinology Research and Practice, 2019
The importance of continuing growth hormone therapy in the transition and adulthood periods must be studied in adolescents with growth hormone deficiency with childhood onset.
Doğuş VURALLI
doaj   +1 more source

Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial

open access: yesBMC Women's Health, 2008
Background The aim of the study was to determine the effect of postmenopausal hormone therapy on women's symptom reporting and quality of life in a randomized trial.
Rahu Mati   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy